BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34738634)

  • 1. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.
    Sokal A; de Nadaï T; Maquet J; Comont T; Limal N; Michel M; Beyne-Rauzy O; Godeau B; Adoue D; Mahévas M; Moulis G;
    Br J Haematol; 2022 Mar; 196(5):1262-1270. PubMed ID: 34738634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.
    Piel-Julian ML; Mahévas M; Germain J; Languille L; Comont T; Lapeyre-Mestre M; Payrastre B; Beyne-Rauzy O; Michel M; Godeau B; Adoue D; Moulis G;
    J Thromb Haemost; 2018 Sep; 16(9):1830-1842. PubMed ID: 29978544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical variations between three different causes of thrombocytopenia.
    Akin S; Haznedaroglu IC
    Niger J Clin Pract; 2021 Jan; 24(1):17-20. PubMed ID: 33473020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of major bleeds in patients with immune thrombocytopenia.
    Mithoowani S; Cervi A; Shah N; Ejaz R; Sirotich E; Barty R; Li N; Nazy I; Arnold DM
    J Thromb Haemost; 2020 Jul; 18(7):1783-1790. PubMed ID: 32219982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
    Tsuda H; Tsuji T; Tsuji M; Yamasaki H
    Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia.
    Ong SY; Tan CW; Ramya V; Malik AA; Lee XH; Hwang JCC; Yang Y; Ng HJ; Lee LH
    Ann Hematol; 2021 Mar; 100(3):645-651. PubMed ID: 33515047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.
    Michel M; Rauzy OB; Thoraval FR; Languille L; Khellaf M; Bierling P; Godeau B
    Am J Hematol; 2011 Dec; 86(12):980-4. PubMed ID: 21956157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
    Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
    Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.
    Schifferli A; Moulis G; Godeau B; Leblanc T; Aladjidi N; Michel M; Leverger G; Elalfy M; Grainger J; Chitlur M; Heiri A; Holzhauer S; Le Gavrian G; Imbach P; Kühne T
    Haematologica; 2023 Oct; 108(10):2783-2793. PubMed ID: 37051753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.
    Neunert C; Noroozi N; Norman G; Buchanan GR; Goy J; Nazi I; Kelton JG; Arnold DM
    J Thromb Haemost; 2015 Mar; 13(3):457-64. PubMed ID: 25495497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.
    Hato T; Shimada N; Kurata Y; Kuwana M; Fujimura K; Kashiwagi H; Takafuta T; Murata M; Tomiyama Y
    Blood Adv; 2020 Apr; 4(8):1648-1655. PubMed ID: 32320469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.
    Le Guenno G; Guieze R; Audia S; Khellaf M; Michel M; Bonnotte B; Ruivard M; Godeau B
    Intern Med J; 2019 Sep; 49(9):1154-1162. PubMed ID: 30816621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
    Li S; Molony JT; Cetin K; Wasser JS; Altomare I
    Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.
    Guillet S; Loustau V; Boutin E; Zarour A; Comont T; Souchaud-Debouverie O; Costedoat Chalumeau N; Pan-Petesch B; Gobert D; Cheze S; Viallard JF; Morin AS; Sauvetre G; Cliquennois M; Royer B; Masseau A; Terriou L; Fieschi C; Lambotte O; Girault S; Lioger B; Audia S; Sacre K; Lega JC; Langlois V; Benachi A; Orvain C; Devidas A; Humbert S; Gambier N; Ruivard M; Zarrouk V; Ebbo M; Willems L; Segaux L; Mahevas M; Haddad B; Michel M; Canoui-Poitrine F; Godeau B
    Blood; 2023 Jan; 141(1):11-21. PubMed ID: 36054922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
    Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
    Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort.
    Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI;
    J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
    Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R
    Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.